Storia in 2 fonti

Medtronic beats quarterly estimates on robust demand for heart devices

Irish-headquartered medtech giant working through spin out of diabetes business and focus on smaller, targeted acquisitions

Raccontata da

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

irishtimes.comStai leggendo3 mesi fa

Irish-headquartered medtech giant working through spin out of diabetes business and focus on smaller, targeted acquisitions

Medtronic (MDT) stock jumps after beating Q4 revenue expectations, driven by strong growth in cardiovascular and diabetes tech.